Guy R. Pilkington, Ph.D.
About Guy R. Pilkington, Ph.D.
Guy R. Pilkington, Ph.D., is a Senior Scientist specializing in Virology at ATCC, with a background in cancer immunotherapy and virology research. He has held various academic and research positions, including roles at the National Cancer Institute and ImQuest BioSciences, and has contributed significantly to the field through innovative methodologies and mentoring.
Current Role at ATCC
Guy R. Pilkington, Ph.D. serves as a Senior Scientist in Virology at ATCC, a position he has held since 2020. In this role, he focuses on advancing research and development in virology. His work contributes to the organization's mission of providing high-quality biological products and services. ATCC is known for its commitment to supporting scientific research and innovation, and Pilkington's expertise in virology plays a significant role in these efforts.
Previous Experience at National Cancer Institute
Prior to his current position, Pilkington worked as a Postdoctoral Research Fellow at the National Cancer Institute from 2008 to 2014. During his six years in Frederick, MD, he engaged in significant research projects that contributed to the understanding of cancer biology. His experience at the National Cancer Institute provided him with a strong foundation in cancer research and immunotherapy.
Educational Background
Guy R. Pilkington earned his Doctor of Philosophy (Ph.D.) in Biochemistry, Molecular and Cellular Biology from the University of Arizona. He also holds a Master of Science (M.Sc.) and a Bachelor of Science (BSc HONS) in Cell Biology and Micro-Anatomy from the University of the Witwatersrand. His educational background equips him with a comprehensive understanding of cellular processes and molecular mechanisms relevant to his research in virology and cancer.
Contributions to Research and Development
Throughout his career, Pilkington has made significant contributions to research and development in virology and cancer immunotherapy. He designed and validated an optimized IL-12 cytokine vector, which has potential applications in cancer treatment. Additionally, he developed a methodology for producing highly purified Hepatitis B virus, which has become a critical resource for clients worldwide. His implementation of new western blotting protocols in laboratories also enhanced efficiency and precision, resulting in substantial cost savings.
Mentorship and Training
In addition to his research contributions, Guy R. Pilkington has played a vital role in mentoring the next generation of scientists. He participated in the NCI Student Internship Program, where he mentored student scientists. This involvement reflects his commitment to fostering scientific talent and supporting the development of future researchers in the field.